Concentra Group Holdings Parent

Valuation Analysis

About the Company

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforce

Concentra Group Holdings Parent Stock at a Glance

Concentra Group Holdings Parent (CON) is currently trading at $28.13 with a market capitalization of $3.6B. The trailing P/E ratio stands at 20.24x, with a forward P/E of 16.56x. The 52-week range spans from $18.55 to $28.20; the current price is 0.2% below the yearly high. Year-over-year revenue growth stands at +13.7%. The net profit margin stands at 7.97%.

💰 Dividend

Concentra Group Holdings Parent pays an annual dividend of $0.25 per share, representing a yield of 0.89%. The payout ratio stands at 17.99%.

📊 Analyst Rating

8 analysts rate Concentra Group Holdings Parent (CON) on consensus: Strong Buy. The average price target is $31.50, implying +11.98% from the current price. Analyst price targets range from $28.00 to $36.00.

Concentra Group Holdings Parent: The Investment Case in Detail

Concentra Group Holdings Parent (CON) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 13.7% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 29.4% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Return on equity of 47% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard.

The Bear Case

The debt-to-equity ratio of 467.74% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn.

What to Watch Next

• The forward P/E of 16.56x is meaningfully below the trailing 20.24x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 99.2% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Concentra Group Holdings Parent?

Compare top-rated brokers — low fees, trusted providers, fully regulated.